Suppr超能文献

基于综合指南的数字化戒烟应用:德国一项全国多中心平行随机对照试验的结果。

Digital Smoking Cessation With a Comprehensive Guideline-Based App-Results of a Nationwide, Multicentric, Parallel, Randomized Controlled Trial in Germany.

机构信息

Outpatient Clinic for Pulmonary Medicine (Pneumologische Praxis im Zentrum (PiZ)), Stuttgart, Germany.

Benningen, Germany.

出版信息

Nicotine Tob Res. 2024 Jun 21;26(7):895-902. doi: 10.1093/ntr/ntae009.

Abstract

BACKGROUND

Smoking tobacco implies significant health hazards. Digital cessation support can get more smokers in contact with guideline-based cessation. The objective was to test the efficacy of a guideline-based smoking cessation app (NichtraucherHelden®). The hypothesis was a significantly higher cessation rate in the intervention group.

METHODS

The study was a nationwide, multicentric, prospective, parallel, randomized controlled trial in Germany from November 2021 to March 2023. Recruitment took place in medical practices and by telephone via study centers. Eligible participants were adult tobacco-dependent smokers according to ICD-10 (F17.2). Randomization (1:1) was operated by a computer-generated stratified 1:1 block procedure. Intervention (IG; n = 336) and control group (CG; n = 325) were briefly advised with regard to stop smoking, IG was additionally treated with the cessation app. The primary endpoint was the self-reported 7-day-point abstinence after 6 months with an intention to treat analysis. Secondary endpoints comprised prolonged abstinence and biochemically verified abstinence. The study was registered at the German Registry of Clinical Trials (DRKS00025933, UTN U1111-1268-2181) and was approved by the competent ethics committees (leading ethic committee Berlin #Eth-52/20).

RESULTS

Three hundred thirty six participants (IG) and 325 (CG) were analyzed. Seven-day point prevalence was significantly higher in the app group (IG) (20% vs. 10%, OR 2.2 (1.4-3.4)). Additionally, the prolonged abstinence and the objective abstinence rates were significantly higher in the app group.

CONCLUSIONS

The NichtraucherHelden app doubles the abstinence rate. Apps can bridge the gap between the small number of therapeutic offers and the need for modern evidence-based cessation support.

IMPLICATIONS

The study is the first to provide evidence for the feasibility and efficacy of guideline-based digital smoking cessation provided by a smartphone app for the German statutory health insurance (SHI) system. Smoking cessation support by smartphone apps could be broadly distributed and thus bring more smokers in contact with guideline-based cessation support than to date and increase the number of successful quitters substantially.

摘要

背景

吸烟对健康有重大危害。数字戒烟支持可以让更多吸烟者接触到基于指南的戒烟方法。本研究旨在测试一款基于指南的戒烟应用程序(NichtraucherHelden®)的疗效。研究假设是干预组的戒烟率显著更高。

方法

这是一项在德国开展的全国性、多中心、前瞻性、平行、随机对照试验,招募工作于 2021 年 11 月至 2023 年 3 月在医疗诊所和研究中心通过电话进行。符合条件的参与者为根据 ICD-10(F17.2)诊断的成年烟草依赖吸烟者。采用计算机生成的分层 1:1 块程序进行随机分组(1:1)。干预组(IG;n=336)和对照组(CG;n=325)仅接受简短的戒烟建议,IG 组还接受戒烟应用程序治疗。主要终点是 6 个月后自我报告的 7 天点戒烟率,采用意向治疗分析。次要终点包括延长的戒烟和生物化学验证的戒烟。该研究在德国临床试验注册处(DRKS00025933,UTN U1111-1268-2181)进行了注册,并获得了相关伦理委员会的批准(柏林主要伦理委员会#Eth-52/20)。

结果

对 336 名参与者(IG)和 325 名参与者(CG)进行了分析。应用程序组(IG)的 7 天点患病率显著更高(20% vs. 10%,OR 2.2(1.4-3.4))。此外,应用程序组的延长戒烟和客观戒烟率也显著更高。

结论

NichtraucherHelden 应用程序将戒烟率提高了一倍。应用程序可以弥合治疗方法数量少与现代基于指南的戒烟支持需求之间的差距。

意义

该研究首次为德国法定健康保险(SHI)系统提供的基于指南的数字戒烟提供了可行性和疗效的证据。通过智能手机应用程序提供的戒烟支持可以广泛推广,从而让更多的吸烟者接触到基于指南的戒烟支持,比以往任何时候都多,并大大增加成功戒烟者的数量。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdbe/11190052/1a29a8d0acd8/ntae009_fig1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验